MORPHEUS: A phase Ib/II study platform evaluating the safety and clinical efficacy of cancer immunotherapy (CIT)-based combinations in gastrointestinal (GI) cancers Meeting Abstract


Authors: Desai, J.; Kortmansky, J. S.; Segal, N. H.; Fakih, M.; Oh, D. Y.; Kim, K. P.; Rahma, O. E.; Ko, A. H.; Chung, H. C.; Alsina, M.; Yeh, K. H.; Li, S.; Al-Sakaff, N. J. A.; Patel, J.; Barak, H.; Wang, J.; Zhang, X.; Bleul, C.; Cha, E.; Lee, J.
Abstract Title: MORPHEUS: A phase Ib/II study platform evaluating the safety and clinical efficacy of cancer immunotherapy (CIT)-based combinations in gastrointestinal (GI) cancers
Meeting Title: 2019 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 4 Suppl.
Meeting Dates: 2019 Jan 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000489107600021
DOI: 10.1200/JCO.2019.37.4_suppl.TPS467
PROVIDER: wos
Notes: Meeting Abstract: TPS467 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neil Howard Segal
    211 Segal
Related MSK Work